Boris Dimitrijeski
A5077003647- Atrial Fibrillation Management and Outcomes
- Acute Ischemic Stroke Management
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Venous Thromboembolism Diagnosis and Management
- Botulinum Toxin and Related Neurological Disorders
- Systemic Sclerosis and Related Diseases
- Intracerebral and Subarachnoid Hemorrhage Research
- Neurological Disorders and Treatments
Vivantes Klinikum
2019-2024
University Hospital Leipzig
2023
Abstract Background The impact of direct oral anticoagulants (DOAC) on haematoma size after intracerebral haemorrhage (ICH) compared to no-anticoagulation is controversial and prospective data are lacking. Methods investigator-initiated, multicentre, RASUNOA-prime study enrolled patients with non-traumatic ICH atrial fibrillation while a DOAC, vitamin K antagonist (VKA) or no anticoagulation (non-OAC). Neuroimaging was reviewed centrally blinded group allocation. Primary endpoint expansion...
Background In patients with acute ischemic stroke, little is known regarding the frequency of abnormal ECG findings other than atrial fibrillation and their association cardiovascular outcomes. We aim to analyze type findings, subsequent changes in medical treatment, outcomes stroke. Methods Results investigator-initiated multicenter MonDAFIS (impact standardized monitoring for detection stroke) study, 3465 stroke or transient attack without were randomized 1:1 receive Holter-ECG up 7 days...
Background Oral anticoagulation (OAC) is key in stroke prevention patients with atrial fibrillation (AF) but there uncertainty regarding the optimal timing of OAC (re)initiation after stroke, as recent large randomised controlled trials have methodological weaknesses and excluded on therapeutic at onset well started a vitamin K antagonist stroke. The ‘1–3–6–12 days rule’, based expert consensus referring to severity, was used clinical practice initiate acute ischaemic or transient attack...
We aimed to analyze prevalence and predictors of NOAC off-label under-dosing in AF patients before after the index stroke.
Abstract Aims The Berlin Atrial Fibrillation Registry was designed to analyse oral anticoagulation (OAC) prescription in patients with atrial fibrillation (AF) and acute ischaemic stroke. Methods results This investigator-initiated prospective multicentre registry enrolled at all 16 stroke units located Berlin, Germany. ongoing telephone follow-up is conducted centrally will cover 5 years per patient. Within 2014 2016, 1080 gave written informed consent 1048 were available for analysis....